fda pulls semaglutide Approves Oral for Weight Loss UT San Antonio study: As

IN AN OPEN LETTER ELI LILLY WROTE IN PART THAT THEY ARE, QUOTE, THE ONLY LAWFUL SUPPLIER OF FDA APPROVED TIRZEPATIDE MEDICINES AND THAT THEY DO NOT PROVIDE THAT INGREDIENT TO COMPOUNDING PHARMACIES, MED SPA WELLNESS CENTERS, ONLINE RETAILERS OR OTHER MANUFACTURERS

Storage: Store at 20C

Why Weight Regain Occurs : Biological adaptations that promoted weight gain initially remain present Appetite and food preoccupation often return when medication stopped Metabolic rate may decrease during weight loss (adaptive thermogenesis) Hormonal changes that defend against weight loss persist Long-Term Management : Most individuals require ongoing medication for sustained weight loss maintenance This is similar to other chronic disease treatments (e.g., blood pressure medications) Obesity is a chronic disease requiring long-term management Strong lifestyle habits help minimize regain but may not prevent it entirely Discuss any plans to discontinue medication with healthcare provider to develop appropriate tapering plan and maintenance strategies

Keep exploring Explore all trials & fda topics

If symptoms do not resolve, additional evaluation should be considered

The membership covers unlimited provider visits, one-on-one health coaching sessions, 24/7 clinical support access, and the weekly check-in and dose adjustment protocol